[1]李 娟,冯双双,康京京,等.尿β2微球蛋白水平与2型糖尿病患者视网膜病变和肾脏病变的相关性[J].医学信息,2020,33(19):99-101.[doi:10.3969/j.issn.1006-1959.2020.19.029]
　LI Juan,FENG Shuang-shuang,KANG Jing-jing,et al.Correlation Between Urine β2 Microglobulin Level and Retinopathy and Nephropathy in Type 2 Diabetic Patients[J].Medical Information,2020,33(19):99-101.[doi:10.3969/j.issn.1006-1959.2020.19.029]
点击复制

尿β2微球蛋白水平与2型糖尿病患者视网膜病变和肾脏病变的相关性()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年19期
页码:
99-101
栏目:
临床研究
出版日期:
2020-10-01

文章信息/Info

Title:
Correlation Between Urine β2 Microglobulin Level and Retinopathy and Nephropathy in Type 2 Diabetic Patients
文章编号:
1006-1959（2020）19-0099-03
作者:
李 娟; 冯双双; 康京京; 牛 敏; 申金付
阜阳市人民医院内分泌科，安徽 阜阳 236000
Author(s):
LI Juan; FENG Shuang-shuang; KANG Jing-jing; NIU Min; SHEN Jin-fu
Department of Endocrinology,Fuyang People’s Hospital,Fuyang 236000,Anhui,China
关键词:
β2微球蛋白; 2型糖尿病; 糖尿病视网膜病变; 糖尿病肾病
Keywords:
β2 microglobulin; Type 2 diabetes; Diabetic retinopathy; Diabetic nephropathy
分类号:
R587
DOI:
10.3969/j.issn.1006-1959.2020.19.029
文献标志码:
A
摘要:
目的 探讨尿液内β2微球蛋白（β2-MG）水平与2型糖尿病视网膜病变和肾损伤的关系。方法 选取2016年2月~2018年11月我院收治的409例2型糖尿病患者为研究对象，根据患者并发症发生情况分为对照组85例、糖尿病视网膜病变（DR）组168例和糖尿病肾损伤（DN）组156例，将糖尿病视网膜病变组进一步分为为非增生性视网膜病变（NPDR）组85例和增生性视网膜病变（PDR）组83例，将糖尿病肾损伤组进一步分为早期肾病组79例和临床肾病组77例。比较糖尿病视网膜病变组和糖尿病肾病组患者尿液β2-MG水平、UmAlb /UCr比值及GFR水平，并分析尿液β2-MG水平与糖尿病视网膜病变（DR）和糖尿病肾病（DN）严重程度的相关性。结果 DR组和DN组尿β2-MG的水平高于对照组，DN组UmAlb /UCr比值及GFR水平高于对照组（P＜0.05）；PDR组尿β2-MG水平高于NPDR组，临床肾病组尿β2-MG的水平高于早期肾病组（P＜0.05），但UmAlb /UCr比值及GFR水平与早期肾病组患者比较，差异无统计学意义（P＞0.05）。Logistic多元回归分析显示，病程、β2-MG是2型糖尿病患者发生视网膜病变的危险因素，Spearman相关分析显示，尿β2-MG水平与DR和DN的严重程度呈正相关（P＜0.05）。结论 糖尿病微血管病变患者尿β2-MG的水平显著升高，可能作为诊断指标为2型DR和肾脏病变的早期诊断提供参考，但仍有待进一步研究。
Abstract:
Objective To investigate the relationship between the level of β2 microglobulin in urine and type 2 diabetic retinopathy and kidney injury. Methods 356 patients with type 2 diabetes who were admitted to our hospital from February 2016 to November 2018 were selected as the research objects. According to the complications of the patients, they were divided into control group 85 cases, diabetic retinopathy group 168 cases and diabetic kidney injury group 156 the diabetic retinopathy group was further divided into non-proliferative retinopathy (NPDR) group with 85 cases and proliferative retinopathy (PDR) group with 83 cases, and the diabetic kidney injury group was further divided into early nephropathy group with 79 cases and clinical nephropathy Group 77 cases. Compare the urine β2-MG level, UmAlb/UCr ratio and GFR level of diabetic retinopathy group and diabetic nephropathy group, and analyze the correlation between urine β2-MG level and the severity of diabetic retinopathy (DR) and diabetic nephropathy (DN).Results The levels of urine β2-MG in the diabetic retinopathy group and the diabetic nephropathy group were higher than those in the control group. The UmAlb/UCr ratio and GFR level in the diabetic nephropathy group were higher than those in the control group(P<0.05); The level of urine β2-MG in the PDR group was higher than that in the NPDR group, and the level of urine β2-MG in the clinical nephropathy group was higher than that in the early nephropathy group(P<0.05), but the UmAlb/UCr ratio and GFR level were the same as those in the early nephropathy group,there was no statistically significant difference among patients (P>0.05). Logistic multiple regression analysis showed that the course of disease and β2-MG were risk factors for retinopathy in patients with type 2 diabetes. Spearman correlation analysis showed that urine β2-MG levels were positively correlated with the severity of DR and DN (P<0.05). Conclusion The level of urine β2-MG in patients with diabetic microangiopathy is significantly increased, which may be used as a diagnostic indicator to provide a reference for the early diagnosis of type 2 diabetic retinopathy and nephropathy, but further research is still needed.

参考文献/References:

[1]Suvi K,Joao RF,Yadi H,et al.IDF Diabetes Atlas:eighth edition[J].International Diabetes Federation,2017. [2]王一鸥,段国平.2型糖尿病患者不同视网膜病变程度下眼表及角膜病变的临床研究[J].国际眼科杂志,2019,19(1):104-106. [3]夏雪影.尿微量白蛋白在2型糖尿病视网膜病变发生发展中的作用[J].兵团医学,2018(3):21-23. [4]Javanmardi M,Azadi NA,Amini S,et al.Diagnostic Value of Cystatin C for Diagnosis of Early Renal Damages in Type 2 Diabetic Mellitus Patients: The First Experience in Iran[J].Journal of research in medical sciences,2015,20(6):571-576. [5]Ushigome E,Hamaguchi M,Matsumoto S,et al.Optimal home SBP targets for preventing the progression of diabetic nephropathy in patients with type 2 diabetes mellitus[J].Journal of Hypertension,2015,33(9):1853-1859. [6]王彬郦.标准化饮食设计在2型糖尿病肥胖患者饮食治疗中的作用[J].检验医学与临床,2016,13(12):1695-1697. [7]王彦春,张俊峰,魏殿军.胱抑素C和β2-微球蛋白对糖尿病肾病早期诊断的价值及相关性[J].广东医学,2014,35(17):2715-2717. [8]Azad N,Agrawal L,Emanuele NV,et al.Association of blood glucose control and pancreatic reserve with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT)[J].Diabetologia,2014,57(6):1124-1131. [9]游小毛,游海燕,梅森林,等.随机尿ACR与血清CysC早期诊断高血压肾病的价值[J].实验与检验医学,2015,33(6):745-746. [10]王晗,罗向霞,冯玉沛,等.糖尿病患者血清胱抑素C、β2-微球蛋白与视网膜病变的关系研究进展[J].中国中医眼科杂志,2017,27(2):122-124.

相似文献/References:

[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
　HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Medical Information,2018,31(19):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
　DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Medical Information,2018,31(19):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
　CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Medical Information,2018,31(19):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(19):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
　LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Medical Information,2018,31(19):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
　GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Medical Information,2022,35(19):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[7]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
　XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Medical Information,2022,35(19):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[8]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
　YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Medical Information,2022,35(19):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[9]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
　ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Medical Information,2022,35(19):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
[10]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行 健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
　LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Medical Information,2018,31(19):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]

更新日期/Last Update: 1900-01-01